ESC 365 - Novel biomarkers and indicators in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study

ESC Premium Access

Novel biomarkers and indicators in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study

Session: Poster session 5 - Univentricular heart, heart failure and pulmonary hypertension in congenital heart diseases

Topic: Grown-up congenital heart disease and surgery

Speaker: Doctor L. Huang (Beijing, CN)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Li Huang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

12 more presentations in this session

Should we leave pulsatile forward flow after the bidirectional Glenn operation?

Speaker: Ms P. Walker-Smith (Bristol, GB)

Outcomes of cardiac pacing in adult Fontan patients

Speaker: Doctor A. Khan (Iowa City, US)

The fate of the pulmonary root after Fontan palliation

Speaker: Doctor M. Possner (Bern, CH)

Cardiac structure and function do not relate to functional capacity in a Fontan cohort

Speaker: Doctor V. Stoll (Oxford, GB)

The evolving use of mechanical circulatory support in pediatric and congenital heart disease patients: an analysis from the German National Register for Congenital Heart Defects

Speaker: Professor O. Tutarel (Berlin, DE)

Access the full session

Poster session 5 - Univentricular heart, heart failure and pulmonary hypertension in congenital heart diseases

Speakers: Doctor L. Huang, Ms P. Walker-Smith, Doctor A. Khan, Doctor M. Possner, Doctor V. Stoll...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources